BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 9658585)

  • 1. Updates in the function and regulation of α
    Akinaga J; García-Sáinz JA; S Pupo A
    Br J Pharmacol; 2019 Jul; 176(14):2343-2357. PubMed ID: 30740663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure-activity relationships of alpha1 adrenergic antagonists.
    Eric S; Solmajer T; Zupan J; Novic M; Oblak M; Agbaba D
    J Mol Model; 2004 Apr; 10(2):139-50. PubMed ID: 14997365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant-negative activity of an alpha(1B)-adrenergic receptor signal-inactivating point mutation.
    Chen S; Lin F; Xu M; Hwa J; Graham RM
    EMBO J; 2000 Aug; 19(16):4265-71. PubMed ID: 10944109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation.
    Scheer A; Fanelli F; Costa T; De Benedetti PG; Cotecchia S
    EMBO J; 1996 Jul; 15(14):3566-78. PubMed ID: 8670860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of critical determinants of alpha 1-adrenergic receptor subtype selective agonist binding.
    Hwa J; Graham RM; Perez DM
    J Biol Chem; 1995 Sep; 270(39):23189-95. PubMed ID: 7559466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.
    Zhao MM; Hwa J; Perez DM
    Mol Pharmacol; 1996 Nov; 50(5):1118-26. PubMed ID: 8913343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligomerization of the alpha 1a- and alpha 1b-adrenergic receptor subtypes. Potential implications in receptor internalization.
    Stanasila L; Perez JB; Vogel H; Cotecchia S
    J Biol Chem; 2003 Oct; 278(41):40239-51. PubMed ID: 12888550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms involved in the activation and regulation of the alpha 1-adrenergic receptor subtypes.
    Cotecchia S; Scheer A; Diviani D; Fanelli F; De Benedetti PG
    Farmaco; 1998 Apr; 53(4):273-7. PubMed ID: 9658585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the interactions between alpha(1)-adrenergic receptors and their antagonists.
    Du L; Li M
    Curr Comput Aided Drug Des; 2010 Sep; 6(3):165-78. PubMed ID: 20412040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K
    Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive activity and inverse agonism at the alpha1adrenoceptors.
    Cotecchia S
    Biochem Pharmacol; 2007 Apr; 73(8):1076-83. PubMed ID: 17125741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms underlying the activation and regulation of the alpha 1B-adrenergic receptor.
    Cotecchia S; Scheer A; Fanelli F; Costa T
    Biochem Soc Trans; 1996 Nov; 24(4):959-63. PubMed ID: 8968492
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.